Shockwave Medical, Inc.

Shockwave Medical is a medical device company specializing in intravascular lithotripsy (IVL) systems for the treatment of cardiovascular calcification. The company manufactures the Shockwave IVL platform, which uses sonic pressure waves to disrupt arterial calcium deposits, enabling improved vessel preparation and reducing complications during interventional cardiology and peripheral vascular procedures. Shockwave offers two primary product lines: Coronary IVL systems for treatment of calcified coronary lesions and Peripheral IVL systems for peripheral arterial disease. The devices are designed to simplify calcium modification with a low complication profile and intuitive user interface. The company serves interventional cardiologists, vascular surgeons, interventional radiologists, and hospitals globally. Shockwave Medical maintains FDA-cleared devices and pursues reimbursement coverage, with ongoing efforts to expand coverage for both coronary and peripheral indications. The company operates from its corporate headquarters in Santa Clara, California, with international offices supporting European markets. Educational initiatives and clinical evidence generation are central to market development strategy.